GoodRx Holdings, Inc. (GDRX)
| Market Cap | 1.31B |
| Revenue (ttm) | 799.87M |
| Net Income (ttm) | 34.60M |
| Shares Out | 347.45M |
| EPS (ttm) | 0.09 |
| PE Ratio | 42.27 |
| Forward PE | 23.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,210,209 |
| Open | 3.900 |
| Previous Close | 3.890 |
| Day's Range | 3.690 - 3.900 |
| 52-Week Range | 3.305 - 6.670 |
| Beta | 1.23 |
| Analysts | Buy |
| Price Target | 5.75 (+52.52%) |
| Earnings Date | Nov 4, 2025 |
About GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price target is $5.75, which is an increase of 52.52% from the latest price.
News
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built f...
GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside
GoodRx is leveraging partnerships with Novo Nordisk and potential TrumpRx involvement to offset stagnating user growth and drive higher-margin revenue. Despite a 14% decline in Monthly Active Consumer...
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
Prescription savings platform GoodRx Holdings Inc. (NASDAQ:GDRX) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct disc...
Exclusive: US pharmacies, drug discounters are discussing TrumpRx role with administration
Retail pharmacies and prescription drug savings site GoodRx are talking with the Trump administration about joining its TrumpRx website, they told Reuters, suggesting an expansion beyond the early des...
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its th...
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® (evolocumab), a cholesterol-lowering...
GoodRx Teams With Kroger on Prescription Savings
Prescription platform GoodRx has launched a brand medication savings solution with supermarket chain Kroger. RxSmartSave, announced Wednesday (Oct. 1), is now available at Kroger pharmacies in 35 stat...
GoodRx expands tie-up with Kroger to offer branded drugs at discounted price
GoodRx said on Wednesday it has partnered with Kroger's healthcare unit to expand its prescription savings services for branded drugs, including Novo Nordisk's popular weight-loss drug Wegovy.
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmar...
GoodRx: Renewed Chance To Sign Up New Customers
GoodRx offers compelling value after a ~50% stock decline over the past 12 months, trading at just 6.1x FY25 adjusted EBITDA despite recent execution challenges. A new Novo Nordisk partnership for Oze...
GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., is riding into new creative territory with the launch of The Savings Wrangler, a ...
Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?
Goodrx Holdings Inc (NASDAQ: GDRX) closed roughly 50% higher on August 18th after Bagsværd-headquartered Novo Nordisk (NYSE: NVO) announced a GLP-1 partnership with the healthcare platform. According ...
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing, driving a 30% stock surge and validating its business model. Pharma Manufacturer Sol...
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the l...
Novo Cuts Price of Ozempic in Half for Cash Buyers
Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer it at the same price at US pharmacies. Bloo...
GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.
GoodRx announces a collaboration with Novo Nordisk to make Ozempic cheaper for self-paying patients.
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozem...
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director of Investor Relations Christopher A. McGinnis - CFO & Treasurer Wen...
GoodRx Reports Second Quarter 2025 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its f...
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and P...
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its se...
GoodRx: A One Big Beautiful Bill Act Beneficiary
GoodRx connects uninsured and underinsured consumers with prescription discounts, acting as a broker between consumers, PBMs, and pharmacies. Recent OBBBA legislation will significantly cut Medicaid s...
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction...
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the indu...
GoodRx: Stabilizing Revenue Amid Healthy Profit Gains
I'm reiterating my Buy rating on GoodRx, as its valuation is compelling and the business is showing signs of stabilization under new leadership. GoodRx's recurring revenue base, expanding pharma partn...